115 related articles for article (PubMed ID: 28891627)
1. [In vitro metabolism of anti-tumor compound E7 in different species of liver microsomes].
Tang MH; Wang HR; Wang CY; Ye HY
Zhongguo Zhong Yao Za Zhi; 2016 May; 41(9):1739-1743. PubMed ID: 28891627
[TBL] [Abstract][Full Text] [Related]
2. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.
Valles B; Schiller CD; Coassolo P; De Sousa G; Wyss R; Jaeck D; Viger-Chougnet A; Rahmani R
Drug Metab Dispos; 1995 Oct; 23(10):1051-7. PubMed ID: 8654192
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic stability and metabolic enzyme phaenotypes of lanceolatin B in liver microsomes of different species by UPLC-MS/MS].
Wang HR; Li XB; Yang QN; Tang MH; Xiao CB; Wan L
Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(1):124-128. PubMed ID: 28845653
[TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism of l-corydalmine, a potent analgesic drug, in human, cynomolgus monkey, beagle dog, rat and mouse liver microsomes.
Tang X; Di X; Zhong Z; Xie Q; Chen Y; Wang F; Ling Z; Xu P; Zhao K; Wang Z; Liu L; Liu X
J Pharm Biomed Anal; 2016 Sep; 128():98-105. PubMed ID: 27239758
[TBL] [Abstract][Full Text] [Related]
6. [In vitro metabolism of forscolin isolated from Coleus forskohlii].
Zhang M; Meng ZY; Zhu XX; Dou GF
Yao Xue Xue Bao; 2013 Mar; 48(3):383-9. PubMed ID: 23724652
[TBL] [Abstract][Full Text] [Related]
7. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.
Li Y; Li NY; Sellers EM
Eur J Drug Metab Pharmacokinet; 1997; 22(4):295-304. PubMed ID: 9512924
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase.
Austin NE; Baldwin SJ; Cutler L; Deeks N; Kelly PJ; Nash M; Shardlow CE; Stemp G; Thewlis K; Ayrton A; Jeffrey P
Xenobiotica; 2001; 31(8-9):677-86. PubMed ID: 11569533
[TBL] [Abstract][Full Text] [Related]
9. [Lidamycin metabolism in vitro].
Wen YQ; Meng ZY; Chen SZ; Zhu XX; Dou GF
Yao Xue Xue Bao; 2011 Sep; 46(9):1132-6. PubMed ID: 22121787
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of dictamnine in liver microsomes from mouse, rat, dog, monkey, and human.
Wang P; Zhao Y; Zhu Y; Sun J; Yerke A; Sang S; Yu Z
J Pharm Biomed Anal; 2016 Feb; 119():166-74. PubMed ID: 26683990
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
[TBL] [Abstract][Full Text] [Related]
12. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
Eberhart DC; Gemzik B; Halvorson MR; Parkinson A
Mol Pharmacol; 1991 Nov; 40(5):859-67. PubMed ID: 1944247
[TBL] [Abstract][Full Text] [Related]
13. Characterization of diuron N-demethylation by mammalian hepatic microsomes and cDNA-expressed human cytochrome P450 enzymes.
Abass K; Reponen P; Turpeinen M; Jalonen J; Pelkonen O
Drug Metab Dispos; 2007 Sep; 35(9):1634-41. PubMed ID: 17576805
[TBL] [Abstract][Full Text] [Related]
14. Characterization of phase I metabolism of resibufogenin and evaluation of the metabolic effects on its antitumor activity and toxicity.
Ning J; Yu ZL; Hu LH; Wang C; Huo XK; Deng S; Hou J; Wu JJ; Ge GB; Ma XC; Yang L
Drug Metab Dispos; 2015 Mar; 43(3):299-308. PubMed ID: 25504504
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of aildenafil in vivo in rats and in vitro in mouse, rat, dog, and human liver microsomes.
Li Y; Wu L; Gu Y; Si D; Liu C
Drug Test Anal; 2014 Jun; 6(6):552-62. PubMed ID: 24311535
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of the trisubstituted purine cyclin-dependent kinase inhibitor seliciclib (R-roscovitine) in vitro and in vivo.
McClue SJ; Stuart I
Drug Metab Dispos; 2008 Mar; 36(3):561-70. PubMed ID: 18048486
[TBL] [Abstract][Full Text] [Related]
17. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs.
Nishimuta H; Houston JB; Galetin A
Drug Metab Dispos; 2014 Sep; 42(9):1522-31. PubMed ID: 24994071
[TBL] [Abstract][Full Text] [Related]
18. Benzydamine N-oxygenation as an index for flavin-containing monooxygenase activity and benzydamine N-demethylation by cytochrome P450 enzymes in liver microsomes from rats, dogs, monkeys, and humans.
Taniguchi-Takizawa T; Shimizu M; Kume T; Yamazaki H
Drug Metab Pharmacokinet; 2015 Feb; 30(1):64-9. PubMed ID: 25760531
[TBL] [Abstract][Full Text] [Related]
19. Species differences in hepatic and intestinal metabolic activities for 43 human cytochrome P450 substrates between humans and rats or dogs.
Nishimuta H; Nakagawa T; Nomura N; Yabuki M
Xenobiotica; 2013 Nov; 43(11):948-55. PubMed ID: 23593983
[TBL] [Abstract][Full Text] [Related]
20. Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans.
Nishimuta H; Sato K; Mizuki Y; Yabuki M; Komuro S
Drug Metab Pharmacokinet; 2011 Jun; 26(3):300-6. PubMed ID: 21383522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
